Evaluating nutrition strategies for pregnant women in Ethiopia
Targeting Strategies of Antenatal Balanced Energy and Protein Supplementation in Addis Ababa, Ethiopia
This study is testing different ways to provide nutrition supplements to pregnant women in Ethiopia to see which method helps improve the health of mothers and their babies.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 6750 (estimated) |
| Ages | 18 Years to 49 Years |
| Sex | Female |
| Sponsor | Harvard School of Public Health (HSPH) Academic / other |
| Locations | 1 site (Addis Ababa, Addis Ababa) |
| Trial ID | NCT06125860 on ClinicalTrials.gov |
What this trial studies
This study aims to assess various strategies for delivering balanced energy and protein (BEP) supplements to pregnant women in Addis Ababa, Ethiopia. It will compare the effectiveness of individual-based targeting strategies against universal provision of BEP supplements in preventing adverse pregnancy outcomes. Participants will be enrolled during pregnancy and monitored through six weeks postpartum to evaluate the impact of these strategies on maternal and child health. The study also seeks to analyze the cost-effectiveness and feasibility of these interventions.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 18 to 49, attending antenatal visits, and with a gestational age of 24 weeks or less.
Not a fit: Patients who do not meet the inclusion criteria, such as those with known allergies to peanuts or soybeans, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve pregnancy outcomes for women and infants in Ethiopia.
How similar studies have performed: Other studies have shown success with targeted nutritional interventions during pregnancy, indicating potential for positive outcomes in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. pregnant women aged 18 to 49; 2. attending antenatal visits in one of the study health facilities; 3. with a gestational age of 24 weeks or less; 4. no known allergies to peanuts or soybeans; 5. having resided in the current location for at least 6 months; 6. intending to continue antenatal follow-up in the health facility; 7. intending to give birth and remain in the study area until six weeks after delivery; and 8. willing to take the BEP supplements for the entire duration of the pregnancy if eligible. Exclusion Criteria: * Not meeting all of the inclusion criteria above
Where this trial is running
Addis Ababa, Addis Ababa
- Addis Continental Institute of Public Health (ACIPH) — Addis Ababa, Addis Ababa, Ethiopia (Recruiting)
Study contacts
- Principal investigator: Wafaie W Fawzi, DrPH, MBBS — Harvard School of Public Health (HSPH)
- Study coordinator: Wafaie W Fawzi, DrPH, MBBS
- Email: mina@hsph.harvard.edu
- Phone: 617-432-7598
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.